PATHOGENIC MECHANISMS IN MYASTHENIA
PATHOGENIC MECHANISMS IN MYASTHENIA
批准号:
2263668
负责人:
DAVID P RICHMAN
金额:
$17.16万
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-07-01 至 1997-06-30
关键词:
中文摘要
重症肌无力及其动物模型--实验性自身免疫
重症肌无力(EAMG)是T细胞依赖抗体(Ab)介导的
针对乙酰胆碱受体(AChR)的自身免疫性疾病
神经肌肉接头终板膜(NMJ)。三大致病
抗体诱导的特征性异常的机制
NMJ是从EAMG和MG的研究中提出的:补体介导的
终板膜破坏通过抗体交联剂增加AChR周转
相邻的AChRs,以及完整AChRs的功能阻断。我们以前的
来自其他实验室的研究和研究提出了这一假说
补体介导的终板膜是其主要作用机制
毁灭。检验这一假设--同基因重组/嵌合体
(REC/CHI)抗体将从我们的大鼠抗AChR单克隆库中制备
ABS,已被设计为具有减少或缺乏补体
激活活动,但保留与另一个相关的功能
两种可能的致病机制。这些记录/CHI抗体将在
体外和体内对它们的抗原结合和效应功能
因为他们能够诱导EAMG的被动转移形式
同基因大鼠。不能诱导EAMG的REC/CHI抗体将
测试,无论是单独测试还是组合测试,测试他们的被动防守能力-
和主动诱导的EAMG。这种类型的ABS可能会表示
新的抗原特异性治疗重症肌无力。因此,类似的人类自体
REC/CHI单抗将由患者获得的抗AChR B细胞发展而来
并对其体外效应功能进行了分析。
英文摘要
Myasthenia gravis (MG) and its animal model, experimental autoimmune
myasthenia gravis (EAMG) are T-cell-dependent antibody (Ab)-mediated
autoimmune disease directed at the acetylcholine receptor (AChR) in the
endplate membrane of the neuromuscular junction (NMJ). Three pathogenic
mechanisms by which the Abs induce the characteristic abnormalities at the
NMJ have been proposed from studies of EAMG and MG: complement-mediated
endplate membrane destruction increased AChR turnover by Ab crosslinking of
adjacent AChRs, and functional blockage of intact AChRs. Our previous
studies and those from other laboratories have suggested the hypothesis
that the major mechanism is complement-mediated endplate membrane
destruction. To test this hypothesis-syngeneic recombinant/chimeric
(rec/chi) Abs will be produced from our library of rat anti-AChR monoclonal
Abs, which have been engineered to have reduced or absent complement
activating activity, but to retain the functions associated with the other
two possible pathogenic mechanisms. These rec/chi Abs will be analyzed in
vitro for their antigen binding and their effector functions and in vivo
for their ability to induce the passively-transferred form of EAMG in
syngeneic rats. Rec/chi Abs that are incapable of inducing EAMG will be
tested, singly or in combination, for their ability to bock both passively-
and actively-induced EAMG. Abs of this type will potentially represent a
new antigen-specific treatment of MG. Therefore, similar human autologous
rec/chi Abs will developed from anti-AChR B cells obtained from patients
with MG, and their effector functions analyzed in vitro.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Animal Models of Anti-MuSK Myasthenia
-
批准号:8048710
-
项目类别:
-
资助金额:$22.96万
-
财政年份:2010
-
负责人:DAVID P RICHMAN
-
依托单位:
Development of Animal Models of Anti-MuSK Myasthenia
-
批准号:8152160
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2010
-
负责人:DAVID P RICHMAN
-
依托单位:
IX INTERNATIONAL CONFERENCE ON MYASTHENIA GRAVIS
-
批准号:2038867
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1997
-
负责人:DAVID P RICHMAN
-
依托单位:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
-
批准号:3100129
-
项目类别:
-
资助金额:$65.68万
-
财政年份:1987
-
负责人:DAVID P RICHMAN
-
依托单位:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
-
批准号:3100128
-
项目类别:
-
资助金额:$18.06万
-
财政年份:1987
-
负责人:DAVID P RICHMAN
-
依托单位:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
-
批准号:3100131
-
项目类别:
-
资助金额:$58.46万
-
财政年份:1987
-
负责人:DAVID P RICHMAN
-
依托单位:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
-
批准号:3100126
-
项目类别:
-
资助金额:$72.85万
-
财政年份:1987
-
负责人:DAVID P RICHMAN
-
依托单位:
STRUCTURE/FUNCTION ANALYSIS OF ACCHR EPITOPES
-
批准号:3100130
-
项目类别:
-
资助金额:$61.12万
-
财政年份:1987
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399867
-
项目类别:
-
资助金额:$16.08万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399864
-
项目类别:
-
资助金额:$10.72万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA
-
批准号:2263670
-
项目类别:
-
资助金额:$22.19万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399865
-
项目类别:
-
资助金额:$11.25万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399863
-
项目类别:
-
资助金额:$10.82万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399859
-
项目类别:
-
资助金额:$12.17万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399860
-
项目类别:
-
资助金额:$19.04万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA
-
批准号:2263669
-
项目类别:
-
资助金额:$21.16万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399862
-
项目类别:
-
资助金额:$10.75万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
PATHOGENIC MECHANISMS IN MYASTHENIA GRAVIS
-
批准号:3399866
-
项目类别:
-
资助金额:$16.73万
-
财政年份:1984
-
负责人:DAVID P RICHMAN
-
依托单位:
ANTIIDIOTYPIC ANTIBODIES IN MYASTHENIA
-
批准号:2262830
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1979
-
负责人:DAVID P RICHMAN
-
依托单位:
ANTI-IDIOTYPIC ANTIBODIES IN MYASTHENIA
-
批准号:3396281
-
项目类别:
-
资助金额:$17.15万
-
财政年份:1979
-
负责人:DAVID P RICHMAN
-
依托单位:
海外基金